Board Meeting12 Oct 2026, 08:00 pm
Sun Pharma Approves INR 10,000 Crore NCD Issuance
AI Summary
Sun Pharmaceutical Industries Limited's Board of Directors met on October 12, 2026, and approved the issuance of listed, rated, unsecured, redeemable non-convertible debentures (NCDs) on a private placement basis. The aggregate amount for these NCDs will not exceed INR 10,000 Crore. The Board also authorized the Finance Committee to finalize tranche-specific terms. Additionally, the Board accepted the resignation of Mr. Gautam Doshi as a Non-Executive, Independent Director due to personal reasons, expressing appreciation for his contributions.
Key Highlights
- Board approved NCD issuance up to INR 10,000 Crore.
- NCDs to be listed, rated, unsecured, and redeemable.
- Issuance will be on a private placement basis.
- Finance Committee authorized for tranche-specific terms.
- Independent Director Gautam Doshi resigned due to personal reasons.
Price Impact
More from SUNPHARMA